Peak6 Investments LLC Prothena Corp Public LTD CO Put Options Transaction History

Peak6 Investments LLC

  • $43.5 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$8.85 - $12.49 $584,985 - $825,589
-66,100 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$10.32 - $14.49 $552,120 - $775,215
-53,500 Reduced 44.73%
66,100 $802,000
Q4 2018

Feb 13, 2019
BUY
$8.73 - $13.74 $927,126 - $1.46 Million
106,200 Added 792.54%
119,600 $1.23 Million
Q3 2018

Nov 13, 2018
BUY
$12.7 - $15.79 $170,180 - $211,586
13,400 New
13,400 $175,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $685M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email